Department of Pharmacology and Toxicology, University of Louisville, KY, USA.
Int J Nanomedicine. 2013;8:3603-17. doi: 10.2147/IJN.S51668. Epub 2013 Oct 1.
Nano-scale particles sized 10-400 nm administered systemically preferentially extravasate from tumor vasculature due to the enhanced permeability and retention effect. Therapeutic success remains elusive, however, because of inhomogeneous particle distribution within tumor tissue. Insufficient tumor vascularization limits particle transport and also results in avascular hypoxic regions with non-proliferating cells, which can regenerate tissue after nanoparticle-delivered cytotoxicity or thermal ablation. Nanoparticle surface modifications provide for increasing tumor targeting and uptake while decreasing immunogenicity and toxicity. Herein, we created novel two layer gold-nanoshell particles coated with alkanethiol and phosphatidylcholine, and three layer nanoshells additionally coated with high-density-lipoprotein. We hypothesize that these particles have enhanced penetration into 3-dimensional cell cultures modeling avascular tissue when compared to standard poly(ethylene glycol) (PEG)-coated nanoshells. Particle uptake and distribution in liver, lung, and pancreatic tumor cell cultures were evaluated using silver-enhancement staining and hyperspectral imaging with dark field microscopy. Two layer nanoshells exhibited significantly higher uptake compared to PEGylated nanoshells. This multilayer formulation may help overcome transport barriers presented by tumor vasculature, and could be further investigated in vivo as a platform for targeted cancer therapies.
纳米级颗粒大小为 10-400nm,全身给药时由于增强的通透性和保留效应,优先从肿瘤血管中外渗。然而,由于肿瘤组织内颗粒分布不均匀,治疗效果仍然难以捉摸。肿瘤血管生成不足限制了颗粒的转运,也导致了乏血管缺氧区域,其中无增殖细胞在纳米颗粒输送的细胞毒性或热消融后可以再生组织。纳米颗粒表面修饰提供了增加肿瘤靶向和摄取的能力,同时降低了免疫原性和毒性。在此,我们创建了新型双层金纳米壳颗粒,用巯基烷和磷脂酰胆碱进行涂层,并在三层纳米壳上额外用高密度脂蛋白进行涂层。我们假设与标准聚乙二醇(PEG)涂层纳米壳相比,这些颗粒在穿透模拟无血管组织的 3D 细胞培养物方面具有增强的穿透能力。使用银增强染色和暗场显微镜的高光谱成像评估了在肝、肺和胰腺肿瘤细胞培养物中的颗粒摄取和分布。与 PEG 化纳米壳相比,双层纳米壳表现出明显更高的摄取。这种多层配方可能有助于克服肿瘤血管呈现的转运障碍,并可作为靶向癌症治疗的平台在体内进一步研究。
Int J Nanomedicine. 2013-10-1
Eur Phys J Plus. 2015-11-1
ACS Appl Mater Interfaces. 2014-11-11
World J Clin Cases. 2022-6-6
Eur J Histochem. 2020-7-1
Nanomaterials (Basel). 2020-3-18
Int J Nanomedicine. 2019-11-7
Front Bioeng Biotechnol. 2019-8-14
New J Phys. 2013-5-8
Genes Cancer. 2011-12
Clin Cancer Res. 2012-6-5